Cassidy Nicola, Fox Lynn, Love Maria, Byrne Irene, Doyle Anne Marie, Korn Bettina, Shanagher Deirdre, Shone Tony, Cullen Matt, Cullen Teresa, Mullaney Philo, O'Carroll Noreen, O'Dowd Gemma, O'Sullivan Tom, Russell Anne-Marie
Irish Lung Fibrosis Association, Dublin, Ireland
Mater Misericordiae University Hospital, Dublin, Ireland.
BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2649-e2656. doi: 10.1136/bmjspcare-2021-003249.
The importance of palliative care in those with advanced fibrotic interstitial lung diseases (F-ILD) is recognised, but the palliative care requirements of patients and caregivers affected by F-ILD regardless of disease course are not established. We set out to explore this and identify optimal solutions in meeting the needs of a F-ILD population in Ireland.
Implementing a World-Café qualitative research approach, we captured insights evolving, iteratively in interactive small group discussions in response to six predefined topics on palliative care and planning for the future. Thirty-nine stakeholders participated in the World-Café including 12 patients, 13 caregivers, 9 healthcare professionals, 4 industry representatives and 1 representative of the clergy.
Palliative care emerged as fundamental to the care and treatment of F-ILDs, regardless of disease progression. Unmet palliative care needs were identified as psychological and social support, disease education, inclusion of caregivers and practical/legal advice for disease progression and end-of-life planning. Participants identified diagnosis as a particularly distressing time for patients and families. They called for the introduction of palliative care discussions at this early-stage alongside improvements in integrated care, specifically increasing the involvement of primary care practitioners in referrals to palliative services.
Patients and caregivers need discussions on palliative care associated with F-ILD to be included at the point of diagnosis. This approach may address persisting inadequacies in service provision previously identified over the course of the last decade in the UK, Ireland and European F-ILD patient charters.
姑息治疗在晚期纤维化间质性肺疾病(F-ILD)患者中的重要性已得到认可,但F-ILD患者及照料者在姑息治疗方面的需求,无论疾病进程如何,尚未明确。我们着手探讨这一问题,并确定满足爱尔兰F-ILD患者群体需求的最佳解决方案。
采用世界咖啡馆定性研究方法,我们在互动式小组讨论中,针对六个关于姑息治疗和未来规划的预定义主题,反复捕捉不断演变的见解。39名利益相关者参与了世界咖啡馆活动,包括12名患者、13名照料者、9名医疗专业人员、4名行业代表和1名神职人员代表。
无论疾病进展如何,姑息治疗已成为F-ILD护理和治疗的基础。未满足的姑息治疗需求被确定为心理和社会支持、疾病教育、照料者的参与以及针对疾病进展和临终规划的实用/法律建议。参与者认为诊断对患者和家庭来说是特别痛苦的时期。他们呼吁在早期阶段引入姑息治疗讨论,同时改善综合护理,特别是增加初级保健从业者在转诊至姑息治疗服务中的参与度。
患者和照料者需要在诊断时就参与有关F-ILD的姑息治疗讨论。这种方法可能解决过去十年在英国、爱尔兰和欧洲F-ILD患者宪章中先前发现的服务提供方面持续存在的不足。